Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-04 Dethlefs Sven EVP, North America Commercial Option exercise · Restricted Share Units −38,538 115,617
2023-03-04 Daniell Richard Exec. VP, European Commercial Option exercise +15,921 85,691
2023-03-04 Daniell Richard Exec. VP, European Commercial Option exercise +33,512 119,203
2023-03-04 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −15,921 0
2023-03-04 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −33,512 100,536
2023-03-03 Weiss Amir Chief Accounting Officer Grant or award · Restricted Share Units +20,717 20,717
2023-03-03 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +94,621 94,621
2023-03-03 Shani Eli EVP,Global Marketing&Portfolio Grant or award · Restricted Share Units +59,760 59,760
2023-03-03 Sabag Mark EVP, International Markets Grant or award · Restricted Share Units +99,601 99,601
2023-03-03 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +199,202 199,202
2023-03-03 Inbar Galia See "Remarks" Grant or award · Restricted Share Units +59,760 59,760
2023-03-03 Hughes Eric A See "Remarks" Grant or award · Restricted Share Units +99,601 99,601
2023-03-03 Francis Richard D President and CEO Grant or award · Restricted Share Units +268,924 268,924
2023-03-03 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +99,601 99,601
2023-03-03 Dethlefs Sven EVP, North America Commercial Grant or award · Restricted Share Units +99,601 99,601
2023-03-03 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +249,003 249,003
2023-02-28 Weiss Amir Chief Accounting Officer Option exercise +3,219 27,777.41
2023-02-28 Weiss Amir Chief Accounting Officer Option exercise · Restricted Share Units −3,219 3,219
2023-02-28 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +18,430 21,404.39
2023-02-28 Stark David Matthew Exec. VP Chief Legal Officer Sale −18,430 $9.89 $182K 2,974.39

Page 31 of 76 · 1,517 trades